Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin: Original Article: Metabolism

Diabetic Medicine

Volumn 26, Issue 2, 2009, Pages 128-133

  Bleyer, A J ^a   Hire, D ^b   Russell, G B ^a   Xu, J ^a   Divers, J ^a   Shihabi, Z ^a   Bowden, D W ^a   Freedman, B I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b North Carolina Baptist Hospital   (United States)

Author keywords

African American; Caucasian; Diabetes mellitus; Glucose; Glycated haemoglobin

Indexed keywords

CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CREATININE BLOOD LEVEL; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; RETROSPECTIVE STUDY;

ADULT; AFRICAN AMERICANS; AGED; BLOOD GLUCOSE; CREATININE; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; RETROSPECTIVE STUDIES;

EID: 60049094080     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02646.x     Document Type: Article

References (23)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2007 30 : S4 S41.
2. 1c targets. A guidance statement from the American College of Physicians. Ann Int Med 2007 147 : 417 422.
3. 1c): a new blood sugar test and its clinical importance. R I Med J 1979 62 : 131 133.
4. 1c levels between African-American and non-Hispanic white adults with diabetes. Diabetes Care 2006 29 : 2130 2136.
5. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with Type 2 diabetes. Diabetes Care 1999 22 : 403 408.
6. Weatherspoon LJ, Kumanyika SK, Ludlow R, Schatz D. Glycemic control in a sample of black and white clinic patients with NIDDM. Diabetes Care 1994 17 : 1148 1153.
7. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med 2005 353 : 692 700.
8. 1c concentrations among US adults with diagnosed diabetes from 1999 to 2004. Diabetes Care 2008 31 : 102 104.
9. 1c. Diabetes Care 2002 25 : 275 278.
10. 1c as an indicator of the degree of glucose intolerance in diabetes. Diabetes 1975 25 : 230 232.
11. Svendsen PA, Lauritzen T, Soegaard U, Nerup J. Glycosylated haemoglobin and steady-state mean blood glucose concentrations in Type 1 (insulin-dependent) diabetes. Diabetalogia 1982 23 : 403 405.
12. 1c assay into estimated average glucose values. Diabetes Care 2008 31 : 1 6.
13. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Int Med 2006 145 : 247 254.
14. Freedman BI, Hsu FC, Langefeld CD, Rich SS, Herrington DM, Carr JJ et al. The impact of ethnicity and sex on subclinical cardiovascular disease: The Diabetes Heart Study. Diabetologia 2005 48 : 2511 2518.
15. Bouma M, Dekker JH, de-Sonnaville JJ, van-der Does FE, Vries HD, Kriegsman DM et al. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with Type 2 diabetes? Diabetes Care 1999 22 : 904 907.
16. 1c in Type 1 diabetes? Diabet Med 2004 21 : 468 470.
17. 1c by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007 30 : 2453 2457.
18. 1c levels than glucose instability. Diabetes Care 2006 29 : 352 355.
19. 1c levels in diabetic subjects on haemodialysis. Kidney Int 2008 73 : 1062 1068.
20. 1c for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007 30 : 2233 2235.
21. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr., Bigger JT et al. Effect of intensive glucose lowering in type 2 diabetes. N Eng J Med 2008 358 : 2545 2559.
22. Bry L, Chen PC, Sacks DB. Effects of haemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001 47 : 153 163.
23. 1c: implications for the assessment of glycemic control. Clin Chem 2008 53 : 897 901.